BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2391975)

  • 1. Comparison of blood-based and asanguineous cardioplegic solutions administered at 4 degrees C. An ultrastructural morphometric study in the dog.
    Axford-Gatley RA; Wilson GJ; Feindel CM
    J Thorac Cardiovasc Surg; 1990 Sep; 100(3):400-9. PubMed ID: 2391975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of myocardial temperatures with multidose cardioplegia versus single-dose cardioplegia and myocardial surface cooling during coronary artery bypass grafting.
    Daily PO; Jones B; Folkerth TL; Dembitsky WP; Moores WY; Reichman RT
    J Thorac Cardiovasc Surg; 1989 May; 97(5):715-24. PubMed ID: 2785234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrograde versus antegrade delivery of cardioplegic solution in myocardial revascularization. A clinical trial in patients with three-vessel coronary artery disease who underwent myocardial revascularization with extensive use of the internal mammary artery.
    Noyez L; van Son JA; van der Werf T; Knape JT; Gimbrère J; van Asten WN; Lacquet LK; Flameng W
    J Thorac Cardiovasc Surg; 1993 May; 105(5):854-63. PubMed ID: 8487564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of controlled reperfusion after ischemia. XX. Reperfusate composition: detrimental effects of initial asanguineous cardioplegic washout after acute coronary occlusion.
    Acar C; Partington MT; Buckberg GD
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):294-302. PubMed ID: 1992240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of distribution beyond coronary stenoses of blood and asanguineous cardioplegic solutions.
    Robertson JM; Buckberg GD; Vinten-Johansen J; Leaf JD
    J Thorac Cardiovasc Surg; 1983 Jul; 86(1):80-6. PubMed ID: 6865468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved heart preservation with UW preservation solution.
    Swanson DK; Pasaoglu I; Berkoff HA; Southard JA; Hegge JO
    J Heart Transplant; 1988; 7(6):456-67. PubMed ID: 3145337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidose blood versus crystalloid cardioplegia. Comparison by quantitative assessment of irreversible myocardial injury.
    Feindel CM; Tait GA; Wilson GJ; Klement P; MacGregor DC
    J Thorac Cardiovasc Surg; 1984 Apr; 87(4):585-95. PubMed ID: 6708578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antegrade cardioplegic infusion with simultaneously controlled coronary sinus occlusion on preservation of regionally ischemic myocardium after acute coronary artery occlusion and reperfusion.
    Sun SC; Raza ST; Tam SK; Laurence R; Cohn LH
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):626-33. PubMed ID: 3172809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of retrograde cardioplegia. II. Advantages of antegrade/retrograde cardioplegia to optimize distribution in jeopardized myocardium.
    Partington MT; Acar C; Buckberg GD; Julia PL
    J Thorac Cardiovasc Surg; 1989 Apr; 97(4):613-22. PubMed ID: 2927165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European versus North American cardioplegia: comparison of Bretschneider's and Roe's cardioplegic solutions in a canine model of cardiopulmonary bypass.
    Wilson GJ; Axford-Gatley RA; Bush BG; Romaschin AD; Mickle DA
    Thorac Cardiovasc Surg; 1990 Feb; 38(1):10-4. PubMed ID: 2106734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation.
    Rousou JA; Engelman RM; Breyer RH; Otani H; Lemeshow S; Das DK
    J Thorac Cardiovasc Surg; 1988 Apr; 95(4):625-30. PubMed ID: 3352296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature-dependent cardioprotection of exogenous substrates in long-term heart preservation with continuous perfusion: twenty-four-hour preservation of isolated rat heart with St. Thomas' Hospital solution containing glucose, insulin, and aspartate.
    Shimada Y; Yamamoto F; Yamamoto H; Oka T; Kawashima Y
    J Heart Lung Transplant; 1996 May; 15(5):485-95. PubMed ID: 8771504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of phosphodiesterase III-inhibitor (E-1020) adjunct to Bretschneider's HTK cardioplegic solution on myocardial preservation in rabbit heart.
    Wang Y; Sunamori M; Suzuki A
    Thorac Cardiovasc Surg; 1996 Aug; 44(4):167-72. PubMed ID: 8896157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
    Kempsford RD; Hearse DJ
    J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioplegic infusion: the safe limits of pressure and temperature.
    Johnson RE; Dorsey LM; Moye SJ; Hatcher CR; Guyton RA
    J Thorac Cardiovasc Surg; 1982 Jun; 83(6):813-24. PubMed ID: 7087508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanoenergetic function and troponin T release following cardioplegic arrest induced by St Thomas' and histidine-tryptophan-ketoglutarate cardioplegia--an experimental comparative study in pigs.
    Aarsaether E; Stenberg TA; Jakobsen Ø; Busund R
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):635-9. PubMed ID: 19628529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial protection during prolonged aortic cross-clamping. Comparison of blood and crystalloid cardioplegia.
    Catinella FP; Cunningham JN; Spencer FC
    J Thorac Cardiovasc Surg; 1984 Sep; 88(3):411-23. PubMed ID: 6471891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of the immature myocardium. An experimental evaluation of topical cooling, single-dose, and multiple-dose administration of St. Thomas' Hospital cardioplegic solution.
    Magovern JA; Pae WE; Waldhausen JA
    J Thorac Cardiovasc Surg; 1988 Sep; 96(3):408-13. PubMed ID: 3411985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic myocardial protection. Comparison of nonoxygenated crystalloid, oxygenated crystalloid, and oxygenated fluorocarbon cardioplegic solutions.
    Tabayashi K; McKeown PP; Miyamoto M; Luedtke AE; Thomas R; Allen MD; Misbach GA; Ivey TD
    J Thorac Cardiovasc Surg; 1988 Feb; 95(2):239-46. PubMed ID: 3339891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.